Biochips Market Research Report – Forecast till 2027

Biochips Market Research Report: by Type (DNA Chips, Lab-On-A-Chip, and Protein Chips), by Technology (Microarrays, and Microfluidics) By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers)-Forecast Till 2027

ID: MRFR/HC/5598-HCR | February 2021 | Region: Global | 90 pages

Biochips Market Scenario


Biochips market is expected to grow significantly over the forecast period. The market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period. Biochips are intended to function in biological environment, preferably inside living organism.

The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications of biochips will boost the market growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.  

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the market.

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease.

Segmentation

The global biochips market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

The biochips global market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market for biochips in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.     

The European biochips market has been segmented into Western Europe and Eastern Europe. The Western Europe biochips market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.      

The biochips market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market for biochips in the Middle East & Africa has been segmented into the Middle East and Africa.      

Key players


Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics are some of the prominent players in the global biochips market.


Regional Market Summary


Global Biochips Share (%), by Region, 2017



Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the biochips global market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region. 

The Middle East & Africa has the lowest share of the global biochips market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector. 

 Global Biochips Market, by Type:



  • DNA chips

    • Gene Expression

    • SNP Genotyping

    • Cancer Diagnosis & Treatment

    • Genomics

    • Drug Discovery

    • Agricultural Biotechnology

    • Others



  • Lab-On-A-Chip

    • Clinical Diagnostics

    • Genomics

    • IVD & POC

    • Proteomics

    • Drug Discovery

    • Others



  • Protein Chips

    • Proteomics

    • Expression Profiling

    • Diagnostics

    • High-Throughput Screening

    • Drug Discovery

    • Others



  • Cell Arrays

  • Tissue Arrays   

  • Others


Global Biochips Market, by Technology:



  • Microarrays

  • Microfluidics


Global Biochips Market, by End User



  • Biotechnology and Pharmaceutical Companies

  • Hospitals and Diagnostics Centers

  • Academic & Research Institutes

  • Others


Global Biochips Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Biochips Market, by Key Players:



  • Perkinelmer, Inc.

  • Fluidigm Corporation

  • Agilent Technologies, Inc.

  • Abbott Laboratories

  • Bio-Rad Laboratories Inc.

  • Cepheid Inc.

  • Illumina, Inc.

  • GE Healthcare

  • Thermo Fisher Scientific, Inc.

  • Roche Diagnostics

  • Others


Intended Audience:



  • Biochips Manufacturers and Distributors

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 7,300 million
  CAGR   2018-2023: 16.6%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, technology, and end user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics
  Key Market Opportunities   High domestic income, and presence of major market
  Key Market Drivers

  • Increasing technological advancements
  • Increasing adoption of personalized medicine


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The biochips market has been projected to achieve with 16.6% CAGR during the forecast period of 2018 to 2023.

    The prime factor to drive the biochips market ahead is technological development.

    The high cost of instruments and strict regulations can prevent the biochips market from growing.

    The biochips market report has technologies like microarrays and microfluidics for discussion.

    The biochips market has end users like hospitals & diagnostics centers, academic & research institutes, biotechnology & pharmaceutical companies, and others.

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Biochips Market, by Type

    6.1 Introduction

    6.2 DNA chips

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Lab-On-A-Chip

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Protein Chips

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 Cell Arrays

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6 Tissue Arrays

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Biochips Market, by Technology

    7.1 Introduction

    7.2 Microarrays

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Microfluidics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Biochips Market, by End User

    8.1 Introduction

    8.2 Biotechnology and Pharmaceutical Companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Hospitals and Diagnostics Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Academic & Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Biochips Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    Chapter 11. Company Profiles

    11.1 Perkinelmer, Inc.

    11.1.1 Company Overview

    11.1.2 Type Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Fluidigm Corporation

    11.2.1 Company Overview

    11.2.2 Type Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Agilent Technologies, Inc.

    11.3.1 Company Overview

    11.3.2 Type Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Abbott Laboratories

    11.4.1 Company Overview

    11.4.2 Type Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Bio-Rad Laboratories Inc.

    11.5.1 Company Overview

    11.5.2 Type Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Cepheid Inc.

    11.6.1 Company Overview

    11.6.2 Type Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Illumina, Inc.

    11.7.1 Overview

    11.7.2 Type Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 GE Healthcare

    11.8.1 Overview

    11.8.2 Type Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Thermo Fisher Scientific

    11.9.1 Overview

    11.9.2 Type Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Roche Diagnostics

    11.10.1 Overview

    11.10.2 Type Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Biochips Industry

    Chapter 13. Appendix


    LIST OF TABLES

    Table 1 Global Biochips Market Synopsis, 2020-2027

    Table 2 Global Biochips Market Estimates and Forecast, 2020-2027

    (USD Million)

    Table 3 Global Biochips Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Biochips Market, by Type, 2020-2027 (USD Million)

    Table 5 Global Biochips Market, by Technology, 2020-2027(USD Million)

    Table 6 Global Biochips Market, by End User, 2020-2027 (USD Million)

    Table 7 North America: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 8 North America: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 9 North America: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 10 US: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 11 US: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 12 US: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 13 Canada: Biochips Market,by Type, 2020-2027 (USD Million)

    Table 14 Canada: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 15 Canada: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 16 South America: Biochips Market, by Type, 2020-2027 (USD

    Million)

    Table 17 South America: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 18 South America: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 19 Europe: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 20 Europe: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 21 Europe: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 22 Western Europe: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 23 Western Europe: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 24 Western Europe: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 25 Eastern Europe: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 26 Eastern Europe: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 27 Eastern Europe: Biochips Market, by End User, 2020-2027(USD Million)

    Table 28 Asia-Pacific: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 29 Asia-Pacific: Biochips Market, by Technology, 2020-2027 (USD Million)

    Table 30 Asia-Pacific: Biochips Market, by End User, 2020-2027 (USD Million)

    Table 31 Middle East & Africa: Biochips Market, by Type, 2020-2027 (USD Million)

    Table 32 Middle East & Africa: Biochips Market, byTechnology, 2020-2027 (USD Million)

    Table 33 Middle East & Africa: Biochips Market, by End User, 2020-2027 (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Biochips Market

    Figure 3 Segmentation Market Dynamics for Global Biochips Market

    Figure 4 Global Biochips Market Share, by Type, 2020

    Figure 5 Global Biochips Market Share, by Technology, 2020

    Figure 6 Global Biochips Market Share, by End User, 2020

    Figure 7 Global Biochips Market Share, by Region, 2020

    Figure 8 North America: Biochips Market Share, by Country, 2020

    Figure 9 Europe: Biochips Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Biochips Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Biochips Market Share, by Country, 2020

    Figure 12 Global Biochips Market: Company Share Analysis, 2020 (%)

    Figure 13 Perkinelmer, Inc. : Key Financials

    Figure 14 Perkinelmer, Inc. : Segmental Revenue

    Figure 15 Perkinelmer, Inc. : Geographical Revenue

    Figure 16 Fluidigm Corporation : Key Financials

    Figure 17 Fluidigm Corporation : Segmental Revenue

    Figure 18 Fluidigm Corporation : Geographical Revenue

    Figure 19 Agilent Technologies, Inc. : Key Financials

    Figure 20 Agilent Technologies, Inc. : Segmental Revenue

    Figure 21 Agilent Technologies, Inc. : Geographical Revenue

    Figure 22 Abbott Laboratories : Key Financials

    Figure 23 Abbott Laboratories : Segmental Revenue

    Figure 24 Abbott Laboratories : Geographical Revenue

    Figure 25 Bio-Rad Laboratories Inc. : Key Financials

    Figure 26 Bio-Rad Laboratories Inc. : Segmental Revenue

    Figure 27 Bio-Rad Laboratories Inc. . Geographical Revenue

    Figure 28 Cepheid Inc. : Key Financials

    Figure 29 Cepheid Inc. : Segmental Revenue

    Figure 30 Cepheid Inc. : Geographical Revenue

    Figure 31 Illumina, Inc. : Key Financials

    Figure 32 Illumina, Inc. : Segmental Revenue

    Figure 33 Illumina, Inc. : Geographical Revenue

    Figure 34 Thermo Fisher Scientific : Key Financials

    Figure 35 Thermo Fisher Scientific : Segmental Revenue

    Figure 36 Thermo Fisher Scientific : Geographical Revenue

    Figure 37 Roche Diagnostics : Key Financials

    Figure 38 Roche Diagnostics : Segmental Revenue

    Figure 39 Roche Diagnostics : Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.